HEADER    VIRAL PROTEIN                           20-DEC-06   2OC7              
TITLE     STRUCTURE OF HEPATITIS C VIRAL NS3 PROTEASE DOMAIN COMPLEXED WITH NS4A
TITLE    2 PEPTIDE AND KETOAMIDE SCH571696                                      
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: HEPATITIS C VIRUS;                                         
COMPND   3 CHAIN: A, C;                                                         
COMPND   4 ENGINEERED: YES;                                                     
COMPND   5 MOL_ID: 2;                                                           
COMPND   6 MOLECULE: HEPATITIS C VIRUS;                                         
COMPND   7 CHAIN: B, D;                                                         
COMPND   8 ENGINEERED: YES;                                                     
COMPND   9 MUTATION: YES                                                        
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS;                              
SOURCE   3 ORGANISM_TAXID: 11103;                                               
SOURCE   4 GENE: NS3;                                                           
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   7 EXPRESSION_SYSTEM_STRAIN: BLR(DE3);                                  
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   9 EXPRESSION_SYSTEM_VECTOR: PET-3A;                                    
SOURCE  10 MOL_ID: 2;                                                           
SOURCE  11 SYNTHETIC: YES                                                       
KEYWDS    HEPATITIS C VIRUS, HCV, NS3 PROTEASE DOMAIN, KETOAMIDE INHIBITOR,     
KEYWDS   2 VIRAL PROTEIN                                                        
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    A.J.PRONGAY,Z.GUO,N.YAO,T.FISCHMANN,C.STRICKLAND,J.MYERS JR.,         
AUTHOR   2 P.C.WEBER,B.MALCOLM,B.M.BEYER,R.INGRAM,J.PICHARDO,Z.HONG,            
AUTHOR   3 W.W.PROSISE,L.RAMANATHAN,S.S.TAREMI,T.YAROSH-TOMAINE,R.ZHANG,        
AUTHOR   4 M.SENIOR,R.YANG,A.ARASAPPAN,F.BENNETT,S.F.BOGEN,K.CHEN,E.JAO,Y.LIU,  
AUTHOR   5 R.G.LOVE,A.K.SAKSENA,S.VENKATRAMAN,V.GIRIJAVALLABHAN,F.G.NJOROGE,    
AUTHOR   6 V.MADISON                                                            
REVDAT   5   30-AUG-23 2OC7    1       REMARK SEQADV LINK                       
REVDAT   4   22-FEB-12 2OC7    1       AUTHOR REMARK                            
REVDAT   3   13-JUL-11 2OC7    1       VERSN                                    
REVDAT   2   24-FEB-09 2OC7    1       VERSN                                    
REVDAT   1   31-JUL-07 2OC7    0                                                
JRNL        AUTH   A.J.PRONGAY,Z.GUO,N.YAO,J.PICHARDO,T.FISCHMANN,C.STRICKLAND, 
JRNL        AUTH 2 J.MYERS JR.,P.C.WEBER,B.M.BEYER,R.INGRAM,Z.HONG,W.W.PROSISE, 
JRNL        AUTH 3 L.RAMANATHAN,S.S.TAREMI,T.YAROSH-TOMAINE,R.ZHANG,M.SENIOR,   
JRNL        AUTH 4 R.S.YANG,B.MALCOLM,A.ARASAPPAN,F.BENNETT,S.L.BOGEN,K.CHEN,   
JRNL        AUTH 5 E.JAO,Y.T.LIU,R.G.LOVEY,A.K.SAKSENA,S.VENKATRAMAN,           
JRNL        AUTH 6 V.GIRIJAVALLABHAN,F.G.NJOROGE,V.MADISON                      
JRNL        TITL   DISCOVERY OF THE HCV NS3/4A PROTEASE INHIBITOR               
JRNL        TITL 2 (1R,5S)-N-[3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL]-3-  
JRNL        TITL 3 [2(S)-[[[(1,1-DIMETHYLETHYL)AMINO]CARBONYL]AMINO]-3,         
JRNL        TITL 4 3-DIMETHYL-1-OXOBUTYL]-                                      
JRNL        TITL 5 6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXAN-2(S)-CARBOXAMIDE (SCH  
JRNL        TITL 6 503034) II. KEY STEPS IN STRUCTURE-BASED OPTIMIZATION.       
JRNL        REF    J.MED.CHEM.                   V.  50  2310 2007              
JRNL        REFN                   ISSN 0022-2623                               
JRNL        PMID   17444623                                                     
JRNL        DOI    10.1021/JM060173K                                            
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   J.L.KIM,K.A.MORGENSTERN,C.LIN,T.FOX,M.D.DWYER,J.A.LANDRO,    
REMARK   1  AUTH 2 S.P.CHAMBERS,W.MARKLAND,C.A.LEPRE,E.T.O'MALLEY,S.L.HARBESON, 
REMARK   1  AUTH 3 C.M.RICE,M.A.MURCKO,P.R.CARON,J.A.THOMSON                    
REMARK   1  TITL   CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS3 PROTEASE      
REMARK   1  TITL 2 DOMAIN COMPLEXED WITH A SYNTHETIC NS4A COFACTOR PEPTIDE.     
REMARK   1  REF    CELL(CAMBRIDGE,MASS.)         V.  87   343 1996              
REMARK   1  REFN                   ISSN 0092-8674                               
REMARK   1  PMID   8861917                                                      
REMARK   1  DOI    10.1016/S0092-8674(00)81351-3                                
REMARK   1 REFERENCE 2                                                          
REMARK   1  AUTH   A.ARASAPPAN,F.G.NJOROGE,T.Y.CHAN,F.BENNETT,S.L.BOGEN,K.CHEN, 
REMARK   1  AUTH 2 H.GU,L.HONG,E.JAO,Y.T.LIU,R.G.LOVEY,T.PAREKH,R.E.PIKE,       
REMARK   1  AUTH 3 P.PINTO,B.SANTHANAM,S.VENKATRAMAN,H.VACCARO,H.WANG,X.YANG,   
REMARK   1  AUTH 4 Z.ZHU,B.MCKITTRICK,A.K.SAKSENA,V.GIRIJAVALLABHAN,J.PICHARDO, 
REMARK   1  AUTH 5 N.BUTKIEWICZ,R.INGRAM,B.MALCOLM,A.PRONGAY,N.YAO,B.MARTEN,    
REMARK   1  AUTH 6 V.MADISON,S.KEMP,O.LEVY,M.LIM-WILBY,S.TAMURA,A.K.GANGULY     
REMARK   1  TITL   HEPATITIS C VIRUS NS3-4A SERINE PROTEASE INHIBITORS: SAR OF  
REMARK   1  TITL 2 P'2 MOIETY WITH IMPROVED POTENCY.                            
REMARK   1  REF    BIOORG.MED.CHEM.LETT.         V.  15  4180 2005              
REMARK   1  REFN                   ISSN 0960-894X                               
REMARK   1  PMID   16087332                                                     
REMARK   1  DOI    10.1016/J.BMCL.2005.06.091                                   
REMARK   1 REFERENCE 3                                                          
REMARK   1  AUTH   K.X.CHEN,F.G.NJOROGE,A.PRONGAY,J.PICHARDO,V.MADISON,         
REMARK   1  AUTH 2 V.GIRIJAVALLABHAN                                            
REMARK   1  TITL   SYNTHESIS AND BIOLOGICAL ACTIVITY OF MACROCYCLIC INHIBITORS  
REMARK   1  TITL 2 OF HEPATITIS C VIRUS (HCV) NS3 PROTEASE.                     
REMARK   1  REF    BIOORG.MED.CHEM.LETT.         V.  15  4475 2005              
REMARK   1  REFN                   ISSN 0960-894X                               
REMARK   1  PMID   16112859                                                     
REMARK   1  DOI    10.1016/J.BMCL.2005.07.033                                   
REMARK   1 REFERENCE 4                                                          
REMARK   1  AUTH   S.BOGEN,A.K.SAKSENA,A.ARASAPPAN,H.GU,F.G.NJOROGE,            
REMARK   1  AUTH 2 V.GIRIJAVALLABHAN,J.PICHARDO,N.BUTKIEWICZ,A.PRONGAY,         
REMARK   1  AUTH 3 V.MADISON                                                    
REMARK   1  TITL   HEPATITIS C VIRUS NS3-4A SERINE PROTEASE INHIBITORS: USE OF  
REMARK   1  TITL 2 A P2-P1 CYCLOPROPYL ALANINE COMBINATION FOR IMPROVED         
REMARK   1  TITL 3 POTENCY.                                                     
REMARK   1  REF    BIOORG.MED.CHEM.LETT.         V.  15  4515 2005              
REMARK   1  REFN                   ISSN 0960-894X                               
REMARK   1  PMID   16112862                                                     
REMARK   1  DOI    10.1016/J.BMCL.2005.07.009                                   
REMARK   1 REFERENCE 5                                                          
REMARK   1  AUTH   S.L.BOGEN,S.RUAN,R.LIU,S.AGRAWAL,J.PICHARDO,A.PRONGAY,       
REMARK   1  AUTH 2 B.BAROUDY,A.K.SAKSENA,V.GIRIJAVALLABHAN,F.G.NJOROGE          
REMARK   1  TITL   DEPEPTIDIZATION EFFORTS ON P3-P2' ALPHA-KETOAMIDE INHIBITORS 
REMARK   1  TITL 2 OF HCV NS3-4A SERINE PROTEASE: EFFECT ON HCV REPLICON        
REMARK   1  TITL 3 ACTIVITY.                                                    
REMARK   1  REF    BIOORG.MED.CHEM.LETT.         V.  16  1621 2006              
REMARK   1  REFN                   ISSN 0960-894X                               
REMARK   1  PMID   16387495                                                     
REMARK   1  DOI    10.1016/J.BMCL.2005.12.013                                   
REMARK   2                                                                      
REMARK   2 RESOLUTION.    2.70 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : X-PLOR 98.1                                          
REMARK   3   AUTHORS     : BRUNGER                                              
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 8.00                           
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 1.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : NULL                           
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : NULL                           
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 79.3                           
REMARK   3   NUMBER OF REFLECTIONS             : 15905                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.193                           
REMARK   3   FREE R VALUE                     : 0.293                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : NULL                            
REMARK   3   FREE R VALUE TEST SET COUNT      : 1573                            
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : NULL                            
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : NULL                         
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.70                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.82                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 37.40                        
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : NULL                         
REMARK   3   BIN R VALUE           (WORKING SET) : 0.3092                       
REMARK   3   BIN FREE R VALUE                    : 0.4824                       
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : NULL                         
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 76                           
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : NULL                         
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2724                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 46                                      
REMARK   3   SOLVENT ATOMS            : 135                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 35.20                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : NULL                           
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : NULL                                                 
REMARK   3    B22 (A**2) : NULL                                                 
REMARK   3    B33 (A**2) : NULL                                                 
REMARK   3    B12 (A**2) : NULL                                                 
REMARK   3    B13 (A**2) : NULL                                                 
REMARK   3    B23 (A**2) : NULL                                                 
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : NULL                            
REMARK   3   ESD FROM SIGMAA              (A) : NULL                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : NULL                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : NULL                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : NULL                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.008                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.855                           
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : NULL                            
REMARK   3   IMPROPER ANGLES        (DEGREES) : 1.467                           
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : ISOTROPIC                                 
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2OC7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAR-07.                  
REMARK 100 THE DEPOSITION ID IS D_1000040952.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : NULL                               
REMARK 200  TEMPERATURE           (KELVIN) : 95                                 
REMARK 200  PH                             : 5.6                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : APS                                
REMARK 200  BEAMLINE                       : 17-ID                              
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.00                               
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 210                   
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : HKL-2000                           
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 18800                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.700                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 50.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 1.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 93.8                               
REMARK 200  DATA REDUNDANCY                : 3.600                              
REMARK 200  R MERGE                    (I) : NULL                               
REMARK 200  R SYM                      (I) : 0.04300                            
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 23.8000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : NULL                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 56.4                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 3.60                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : 0.26700                            
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 2.200                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR                          
REMARK 200 SOFTWARE USED: X-PLOR                                                
REMARK 200 STARTING MODEL: 2O8M                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 68.33                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.88                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: THE PROTEIN (NS3 COMPLEXED WITH KK       
REMARK 280  -NS4A(21-39)-KK PEPTIDE) WAS AT 12-15 MG/ML IN 15 MM MES, PH 6.5,   
REMARK 280  1 M NACL, 20 MM B-MERCAPTOETHANOL. HANGING DROPS WERE FORMED BY     
REMARK 280  MIXING 4:L PROTEIN SOLUTION WITH 4:L {0.75-1.0 M NACL, 0.1M NA/K    
REMARK 280  PHOSPHATE, 0.1 M MES, PH 5.8-6.1, 20 MM 2-MERCAPTOETHANOL} THE      
REMARK 280  DROP WAS EQUILIBRATED THE DROPS OVER 1 ML {(1.25-1.50 M) NACL -     
REMARK 280  0.1M NA/K PHOSPHATE 0.1 M MES, PH 5.6-5.8, 20 MM 2-                 
REMARK 280  MERCAPTOETHANOL} , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE       
REMARK 280  277K                                                                
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 2                            
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -Y,X-Y,Z                                                
REMARK 290       3555   -X+Y,-X,Z                                               
REMARK 290       4555   Y,X,-Z                                                  
REMARK 290       5555   X-Y,-Y,-Z                                               
REMARK 290       6555   -X,-X+Y,-Z                                              
REMARK 290       7555   X+2/3,Y+1/3,Z+1/3                                       
REMARK 290       8555   -Y+2/3,X-Y+1/3,Z+1/3                                    
REMARK 290       9555   -X+Y+2/3,-X+1/3,Z+1/3                                   
REMARK 290      10555   Y+2/3,X+1/3,-Z+1/3                                      
REMARK 290      11555   X-Y+2/3,-Y+1/3,-Z+1/3                                   
REMARK 290      12555   -X+2/3,-X+Y+1/3,-Z+1/3                                  
REMARK 290      13555   X+1/3,Y+2/3,Z+2/3                                       
REMARK 290      14555   -Y+1/3,X-Y+2/3,Z+2/3                                    
REMARK 290      15555   -X+Y+1/3,-X+2/3,Z+2/3                                   
REMARK 290      16555   Y+1/3,X+2/3,-Z+2/3                                      
REMARK 290      17555   X-Y+1/3,-Y+2/3,-Z+2/3                                   
REMARK 290      18555   -X+1/3,-X+Y+2/3,-Z+2/3                                  
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   3 -0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   3 -0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   4 -0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   4  0.866025  0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   5  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   5  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   5  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   6 -0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   6 -0.866025  0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   6  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   7  1.000000  0.000000  0.000000      112.33800            
REMARK 290   SMTRY2   7  0.000000  1.000000  0.000000       64.85837            
REMARK 290   SMTRY3   7  0.000000  0.000000  1.000000       25.20133            
REMARK 290   SMTRY1   8 -0.500000 -0.866025  0.000000      112.33800            
REMARK 290   SMTRY2   8  0.866025 -0.500000  0.000000       64.85837            
REMARK 290   SMTRY3   8  0.000000  0.000000  1.000000       25.20133            
REMARK 290   SMTRY1   9 -0.500000  0.866025  0.000000      112.33800            
REMARK 290   SMTRY2   9 -0.866025 -0.500000  0.000000       64.85837            
REMARK 290   SMTRY3   9  0.000000  0.000000  1.000000       25.20133            
REMARK 290   SMTRY1  10 -0.500000  0.866025  0.000000      112.33800            
REMARK 290   SMTRY2  10  0.866025  0.500000  0.000000       64.85837            
REMARK 290   SMTRY3  10  0.000000  0.000000 -1.000000       25.20133            
REMARK 290   SMTRY1  11  1.000000  0.000000  0.000000      112.33800            
REMARK 290   SMTRY2  11  0.000000 -1.000000  0.000000       64.85837            
REMARK 290   SMTRY3  11  0.000000  0.000000 -1.000000       25.20133            
REMARK 290   SMTRY1  12 -0.500000 -0.866025  0.000000      112.33800            
REMARK 290   SMTRY2  12 -0.866025  0.500000  0.000000       64.85837            
REMARK 290   SMTRY3  12  0.000000  0.000000 -1.000000       25.20133            
REMARK 290   SMTRY1  13  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2  13  0.000000  1.000000  0.000000      129.71675            
REMARK 290   SMTRY3  13  0.000000  0.000000  1.000000       50.40267            
REMARK 290   SMTRY1  14 -0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2  14  0.866025 -0.500000  0.000000      129.71675            
REMARK 290   SMTRY3  14  0.000000  0.000000  1.000000       50.40267            
REMARK 290   SMTRY1  15 -0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2  15 -0.866025 -0.500000  0.000000      129.71675            
REMARK 290   SMTRY3  15  0.000000  0.000000  1.000000       50.40267            
REMARK 290   SMTRY1  16 -0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2  16  0.866025  0.500000  0.000000      129.71675            
REMARK 290   SMTRY3  16  0.000000  0.000000 -1.000000       50.40267            
REMARK 290   SMTRY1  17  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2  17  0.000000 -1.000000  0.000000      129.71675            
REMARK 290   SMTRY3  17  0.000000  0.000000 -1.000000       50.40267            
REMARK 290   SMTRY1  18 -0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2  18 -0.866025  0.500000  0.000000      129.71675            
REMARK 290   SMTRY3  18  0.000000  0.000000 -1.000000       50.40267            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC                        
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC                 
REMARK 350 SOFTWARE USED: PISA,PQS                                              
REMARK 350 TOTAL BURIED SURFACE AREA: 7740 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 15180 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -127.0 KCAL/MOL                       
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D                            
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     MET A   -10                                                      
REMARK 465     ALA A    -9                                                      
REMARK 465     SER A    -8                                                      
REMARK 465     MET A    -7                                                      
REMARK 465     THR A    -6                                                      
REMARK 465     GLY A    -5                                                      
REMARK 465     GLY A    -4                                                      
REMARK 465     GLN A    -3                                                      
REMARK 465     GLN A    -2                                                      
REMARK 465     MET A    -1                                                      
REMARK 465     GLY A     0                                                      
REMARK 465     GLY A   182                                                      
REMARK 465     SER A   183                                                      
REMARK 465     HIS A   184                                                      
REMARK 465     HIS A   185                                                      
REMARK 465     HIS A   186                                                      
REMARK 465     HIS A   187                                                      
REMARK 465     HIS A   188                                                      
REMARK 465     HIS A   189                                                      
REMARK 465     LYS B    19                                                      
REMARK 465     MET C   -10                                                      
REMARK 465     ALA C    -9                                                      
REMARK 465     SER C    -8                                                      
REMARK 465     MET C    -7                                                      
REMARK 465     THR C    -6                                                      
REMARK 465     GLY C    -5                                                      
REMARK 465     GLY C    -4                                                      
REMARK 465     GLN C    -3                                                      
REMARK 465     GLN C    -2                                                      
REMARK 465     MET C    -1                                                      
REMARK 465     GLY C     0                                                      
REMARK 465     ALA C     1                                                      
REMARK 465     PRO C     2                                                      
REMARK 465     ILE C     3                                                      
REMARK 465     THR C     4                                                      
REMARK 465     ALA C     5                                                      
REMARK 465     TYR C     6                                                      
REMARK 465     ALA C     7                                                      
REMARK 465     GLN C     8                                                      
REMARK 465     GLN C     9                                                      
REMARK 465     THR C    10                                                      
REMARK 465     ARG C    11                                                      
REMARK 465     GLY C    12                                                      
REMARK 465     LEU C    13                                                      
REMARK 465     LEU C    14                                                      
REMARK 465     GLY C    15                                                      
REMARK 465     CYS C    16                                                      
REMARK 465     ILE C    17                                                      
REMARK 465     ILE C    18                                                      
REMARK 465     THR C    19                                                      
REMARK 465     SER C    20                                                      
REMARK 465     LEU C    21                                                      
REMARK 465     THR C    22                                                      
REMARK 465     GLY C    23                                                      
REMARK 465     ARG C    24                                                      
REMARK 465     ASP C    25                                                      
REMARK 465     LYS C    26                                                      
REMARK 465     ASN C    27                                                      
REMARK 465     GLN C    28                                                      
REMARK 465     ARG C   180                                                      
REMARK 465     SER C   181                                                      
REMARK 465     GLY C   182                                                      
REMARK 465     SER C   183                                                      
REMARK 465     HIS C   184                                                      
REMARK 465     HIS C   185                                                      
REMARK 465     HIS C   186                                                      
REMARK 465     HIS C   187                                                      
REMARK 465     HIS C   188                                                      
REMARK 465     HIS C   189                                                      
REMARK 465     LYS D    19                                                      
REMARK 465     LYS D    20                                                      
REMARK 465     ILE D    37                                                      
REMARK 465     ILE D    38                                                      
REMARK 465     PRO D    39                                                      
REMARK 465     LYS D    40                                                      
REMARK 465     LYS D    41                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500  ZN     ZN A   901     O    HOH A  1000              1.52            
REMARK 500   SG   CYS A    16     S2   BME A   801              2.03            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    THR A  38     -167.24   -109.60                                   
REMARK 500    HIS A  57        7.46    -65.06                                   
REMARK 500    GLN A  89      109.17    -56.38                                   
REMARK 500    SER A 101      136.78     84.95                                   
REMARK 500    PRO B  35      137.63    -39.57                                   
REMARK 500    ASN C  77       84.69   -163.08                                   
REMARK 500    PRO C  88     -176.92    -65.38                                   
REMARK 500    ALA C 111       31.96     71.93                                   
REMARK 500    PHE C 154      109.25    -53.62                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 901                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN C 901                  
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC3                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 801                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC4                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HU4 A 999                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 2OBO   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF HCV NS3-NS4A COMPLEXED WITH KETOAMIDE SCH476776         
REMARK 900 RELATED ID: 2OC1   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF HCV NS3-NS4A COMPLEXED WITH KETOAMIDE CVS4819           
REMARK 900 RELATED ID: 2OC0   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF HCV NS3-NS4A COMPLEXED WITH KETOAMIDE SCH491762         
DBREF  2OC7 A    1   181  UNP    Q9ELS8   Q9ELS8_9HEPC  1027   1207             
DBREF  2OC7 C    1   181  UNP    Q9ELS8   Q9ELS8_9HEPC  1027   1207             
DBREF  2OC7 B   21    39  UNP    Q9QP06   Q9QP06_9HEPC  1678   1696             
DBREF  2OC7 D   21    39  UNP    Q9QP06   Q9QP06_9HEPC  1678   1696             
SEQADV 2OC7 MET A  -10  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 ALA A   -9  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 SER A   -8  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 MET A   -7  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 THR A   -6  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 GLY A   -5  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 GLY A   -4  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 GLN A   -3  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 GLN A   -2  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 MET A   -1  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 GLY A    0  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 ARG A  119  UNP  Q9ELS8    GLN  1145 CONFLICT                       
SEQADV 2OC7 GLY A  182  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 SER A  183  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 HIS A  184  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 HIS A  185  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 HIS A  186  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 HIS A  187  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 HIS A  188  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 HIS A  189  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 MET C  -10  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 ALA C   -9  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 SER C   -8  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 MET C   -7  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 THR C   -6  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 GLY C   -5  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 GLY C   -4  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 GLN C   -3  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 GLN C   -2  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 MET C   -1  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 GLY C    0  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 ARG C  119  UNP  Q9ELS8    GLN  1145 CONFLICT                       
SEQADV 2OC7 GLY C  182  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 SER C  183  UNP  Q9ELS8              CLONING ARTIFACT               
SEQADV 2OC7 HIS C  184  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 HIS C  185  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 HIS C  186  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 HIS C  187  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 HIS C  188  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 HIS C  189  UNP  Q9ELS8              EXPRESSION TAG                 
SEQADV 2OC7 LYS B   19  UNP  Q9QP06              CLONING ARTIFACT               
SEQADV 2OC7 LYS B   20  UNP  Q9QP06              CLONING ARTIFACT               
SEQADV 2OC7 LYS B   40  UNP  Q9QP06              CLONING ARTIFACT               
SEQADV 2OC7 LYS B   41  UNP  Q9QP06              CLONING ARTIFACT               
SEQADV 2OC7 LYS D   19  UNP  Q9QP06              CLONING ARTIFACT               
SEQADV 2OC7 LYS D   20  UNP  Q9QP06              CLONING ARTIFACT               
SEQADV 2OC7 LYS D   40  UNP  Q9QP06              CLONING ARTIFACT               
SEQADV 2OC7 LYS D   41  UNP  Q9QP06              CLONING ARTIFACT               
SEQRES   1 A  200  MET ALA SER MET THR GLY GLY GLN GLN MET GLY ALA PRO          
SEQRES   2 A  200  ILE THR ALA TYR ALA GLN GLN THR ARG GLY LEU LEU GLY          
SEQRES   3 A  200  CYS ILE ILE THR SER LEU THR GLY ARG ASP LYS ASN GLN          
SEQRES   4 A  200  VAL GLU GLY GLU VAL GLN ILE VAL SER THR ALA THR GLN          
SEQRES   5 A  200  THR PHE LEU ALA THR CYS ILE ASN GLY VAL CYS TRP THR          
SEQRES   6 A  200  VAL TYR HIS GLY ALA GLY THR ARG THR ILE ALA SER PRO          
SEQRES   7 A  200  LYS GLY PRO VAL ILE GLN MET TYR THR ASN VAL ASP GLN          
SEQRES   8 A  200  ASP LEU VAL GLY TRP PRO ALA PRO GLN GLY SER ARG SER          
SEQRES   9 A  200  LEU THR PRO CYS THR CYS GLY SER SER ASP LEU TYR LEU          
SEQRES  10 A  200  VAL THR ARG HIS ALA ASP VAL ILE PRO VAL ARG ARG ARG          
SEQRES  11 A  200  GLY ASP SER ARG GLY SER LEU LEU SER PRO ARG PRO ILE          
SEQRES  12 A  200  SER TYR LEU LYS GLY SER SER GLY GLY PRO LEU LEU CYS          
SEQRES  13 A  200  PRO ALA GLY HIS ALA VAL GLY LEU PHE ARG ALA ALA VAL          
SEQRES  14 A  200  CYS THR ARG GLY VAL ALA LYS ALA VAL ASP PHE ILE PRO          
SEQRES  15 A  200  VAL GLU ASN LEU GLU THR THR MET ARG SER GLY SER HIS          
SEQRES  16 A  200  HIS HIS HIS HIS HIS                                          
SEQRES   1 B   23  LYS LYS GLY SER VAL VAL ILE VAL GLY ARG ILE VAL LEU          
SEQRES   2 B   23  SER GLY LYS PRO ALA ILE ILE PRO LYS LYS                      
SEQRES   1 C  200  MET ALA SER MET THR GLY GLY GLN GLN MET GLY ALA PRO          
SEQRES   2 C  200  ILE THR ALA TYR ALA GLN GLN THR ARG GLY LEU LEU GLY          
SEQRES   3 C  200  CYS ILE ILE THR SER LEU THR GLY ARG ASP LYS ASN GLN          
SEQRES   4 C  200  VAL GLU GLY GLU VAL GLN ILE VAL SER THR ALA THR GLN          
SEQRES   5 C  200  THR PHE LEU ALA THR CYS ILE ASN GLY VAL CYS TRP THR          
SEQRES   6 C  200  VAL TYR HIS GLY ALA GLY THR ARG THR ILE ALA SER PRO          
SEQRES   7 C  200  LYS GLY PRO VAL ILE GLN MET TYR THR ASN VAL ASP GLN          
SEQRES   8 C  200  ASP LEU VAL GLY TRP PRO ALA PRO GLN GLY SER ARG SER          
SEQRES   9 C  200  LEU THR PRO CYS THR CYS GLY SER SER ASP LEU TYR LEU          
SEQRES  10 C  200  VAL THR ARG HIS ALA ASP VAL ILE PRO VAL ARG ARG ARG          
SEQRES  11 C  200  GLY ASP SER ARG GLY SER LEU LEU SER PRO ARG PRO ILE          
SEQRES  12 C  200  SER TYR LEU LYS GLY SER SER GLY GLY PRO LEU LEU CYS          
SEQRES  13 C  200  PRO ALA GLY HIS ALA VAL GLY LEU PHE ARG ALA ALA VAL          
SEQRES  14 C  200  CYS THR ARG GLY VAL ALA LYS ALA VAL ASP PHE ILE PRO          
SEQRES  15 C  200  VAL GLU ASN LEU GLU THR THR MET ARG SER GLY SER HIS          
SEQRES  16 C  200  HIS HIS HIS HIS HIS                                          
SEQRES   1 D   23  LYS LYS GLY SER VAL VAL ILE VAL GLY ARG ILE VAL LEU          
SEQRES   2 D   23  SER GLY LYS PRO ALA ILE ILE PRO LYS LYS                      
HET     ZN  A 901       1                                                       
HET    BME  A 801       4                                                       
HET    HU4  A 999      40                                                       
HET     ZN  C 901       1                                                       
HETNAM      ZN ZINC ION                                                         
HETNAM     BME BETA-MERCAPTOETHANOL                                             
HETNAM     HU4 TERT-BUTYL {(1S)-2-[(1R,2S,5R)-2-({[(1S)-3-AMINO-1-              
HETNAM   2 HU4  (CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL]AMINO}CARBONYL)-7,           
HETNAM   3 HU4  7-DIMETHYL-6-OXA-3-AZABICYCLO[3.2.0]HEPT-3-YL]-1-               
HETNAM   4 HU4  CYCLOHEXYL-2-OXOETHYL}CARBAMATE                                 
HETSYN     HU4 KETOAMIDE INHIBITOR SCH571696, BOUND FORM                        
FORMUL   5   ZN    2(ZN 2+)                                                     
FORMUL   6  BME    C2 H6 O S                                                    
FORMUL   7  HU4    C29 H46 N4 O7                                                
FORMUL   9  HOH   *135(H2 O)                                                    
HELIX    1   1 GLY A   12  GLY A   23  1                                  12    
HELIX    2   2 TYR A   56  GLY A   60  1                                   5    
HELIX    3   3 ILE A  132  LYS A  136  1                                   5    
HELIX    4   4 VAL A  172  ARG A  180  1                                   9    
HELIX    5   5 TYR C   56  GLY C   60  1                                   5    
HELIX    6   6 SER C  133  LEU C  135  5                                   3    
HELIX    7   7 VAL C  172  MET C  179  1                                   8    
SHEET    1   A 4 TYR A   6  GLN A   9  0                                        
SHEET    2   A 4 SER B  22  VAL B  30 -1  O  ARG B  28   N  GLN A   8           
SHEET    3   A 4 THR A  63  SER A  66  1  N  THR A  63   O  VAL B  23           
SHEET    4   A 4 GLY A  69  VAL A  71 -1  O  VAL A  71   N  ILE A  64           
SHEET    1   B 7 TYR A   6  GLN A   9  0                                        
SHEET    2   B 7 SER B  22  VAL B  30 -1  O  ARG B  28   N  GLN A   8           
SHEET    3   B 7 VAL A  33  SER A  37 -1  N  SER A  37   O  VAL B  24           
SHEET    4   B 7 THR A  42  ILE A  48 -1  O  ALA A  45   N  GLN A  34           
SHEET    5   B 7 VAL A  51  VAL A  55 -1  O  TRP A  53   N  THR A  46           
SHEET    6   B 7 LEU A  82  PRO A  86 -1  O  TRP A  85   N  CYS A  52           
SHEET    7   B 7 TYR A  75  ASN A  77 -1  N  ASN A  77   O  LEU A  82           
SHEET    1   C 7 ASP A 103  VAL A 107  0                                        
SHEET    2   C 7 VAL A 113  ARG A 118 -1  O  VAL A 116   N  LEU A 104           
SHEET    3   C 7 ARG A 123  PRO A 131 -1  O  SER A 125   N  ARG A 117           
SHEET    4   C 7 VAL A 163  PRO A 171 -1  O  LYS A 165   N  LEU A 126           
SHEET    5   C 7 ALA A 150  THR A 160 -1  N  VAL A 158   O  ALA A 166           
SHEET    6   C 7 PRO A 142  LEU A 144 -1  N  LEU A 143   O  VAL A 151           
SHEET    7   C 7 ASP A 103  VAL A 107 -1  N  TYR A 105   O  LEU A 144           
SHEET    1   D 3 ALA B  36  ILE B  37  0                                        
SHEET    2   D 3 SER D  22  VAL D  30 -1  O  VAL D  30   N  ALA B  36           
SHEET    3   D 3 THR C  63  ILE C  64  1  N  THR C  63   O  VAL D  23           
SHEET    1   E 7 ALA B  36  ILE B  37  0                                        
SHEET    2   E 7 SER D  22  VAL D  30 -1  O  VAL D  30   N  ALA B  36           
SHEET    3   E 7 VAL C  33  SER C  37 -1  N  ILE C  35   O  VAL D  26           
SHEET    4   E 7 THR C  42  ILE C  48 -1  O  ALA C  45   N  GLN C  34           
SHEET    5   E 7 VAL C  51  VAL C  55 -1  O  TRP C  53   N  THR C  46           
SHEET    6   E 7 LEU C  82  PRO C  86 -1  O  TRP C  85   N  CYS C  52           
SHEET    7   E 7 TYR C  75  ASN C  77 -1  N  TYR C  75   O  GLY C  84           
SHEET    1   F 7 ASP C 103  VAL C 107  0                                        
SHEET    2   F 7 VAL C 113  GLY C 120 -1  O  ILE C 114   N  LEU C 106           
SHEET    3   F 7 ARG C 123  PRO C 131 -1  O  SER C 125   N  ARG C 117           
SHEET    4   F 7 VAL C 163  PRO C 171 -1  O  VAL C 167   N  GLY C 124           
SHEET    5   F 7 ALA C 150  THR C 160 -1  N  ALA C 156   O  ASP C 168           
SHEET    6   F 7 PRO C 142  LEU C 144 -1  N  LEU C 143   O  VAL C 151           
SHEET    7   F 7 ASP C 103  VAL C 107 -1  N  TYR C 105   O  LEU C 144           
LINK         OG  SER A 139                 C37 HU4 A 999     1555   1555  1.43  
SITE     1 AC1  6 CYS A  97  THR A  98  CYS A  99  SER A 101                    
SITE     2 AC1  6 CYS A 145  HOH A1000                                          
SITE     1 AC2  4 CYS C  97  CYS C  99  CYS C 145  HOH C 912                    
SITE     1 AC3  3 CYS A  16  ILE A  17  ALA A  39                               
SITE     1 AC4 13 GLN A  41  HIS A  57  ARG A 123  LEU A 135                    
SITE     2 AC4 13 GLY A 137  SER A 138  SER A 139  PHE A 154                    
SITE     3 AC4 13 ARG A 155  ALA A 156  ALA A 157  CYS A 159                    
SITE     4 AC4 13 ASP A 168                                                     
CRYST1  224.676  224.676   75.604  90.00  90.00 120.00 H 3 2        36          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.004451  0.002569  0.000000        0.00000                         
SCALE2      0.000000  0.005139  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.013227        0.00000